Ultragenyx Pharmaceutical
Earnings Date & Report
Last updated:
Ultragenyx Pharmaceutical’s last earnings date was on 2 May 2024.
Ultragenyx Pharmaceutical stock Earnings report, Estimates & History
| 2019-11-05 | -1.68 | -1.96 |
|---|---|---|
| 2020-02-13 | -1.65 | -1.62 |
| 2020-05-06 | -1.68 | -1.91 |
| 2020-07-30 | -1.54 | 0.41 |
| 2020-10-27 | -1.26 | -1.13 |
| 2021-02-11 | -1.15 | -0.37 |
| 2021-05-04 | -1.24 | -2.03 |
| 2021-08-02 | -1.33 | -1.81 |
| 2021-11-02 | -1.41 | -1.08 |
| 2022-02-10 | -1.34 | -1.79 |
| 2022-05-05 | -1.76 | -2.19 |
| 2022-07-28 | -1.75 | -2.26 |
| 2022-11-02 | -1.81 | -3.5 |
| 2023-02-16 | -2.14 | -2.16 |
| 2023-05-04 | -1.98 | -2.33 |
| 2023-08-03 | -2.07 | -2.26 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Ultragenyx Pharmaceutical stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 2 May 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 14 Feb 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 31 Oct 2023 | N/A | N/A | N/A | N/A | N/A | |
| 3 Aug 2023 | Missed | -$2.07 | -$2.26 | 104.8M | N/A | Earnings Call Transcript |
| 4 May 2023 | Missed | -$1.98 | -$2.33 | 104.69M | 100.49M | Earnings Call Transcript |
| 16 Feb 2023 | Missed | -$2.14 | -$2.16 | 96.2M | 103.34M | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | -$2.16 | N/A | 103.34M | |
| 2 Nov 2022 | Missed | -$1.81 | -$3.5 | N/A | 90.70M | Earnings Call Transcript |
| 28 Jul 2022 | Missed | -$1.75 | -$2.26 | 63.30M | 89.34M | Earnings Call Transcript |
| 5 May 2022 | Missed | -$1.76 | -$2.19 | 60.40M | 79.93M | Earnings Call Transcript |
| 10 Feb 2022 | Missed | -$1.34 | -$1.79 | 83.12M | 83.38M | Earnings Call Transcript |
| 2 Nov 2021 | Beat | -$1.41 | -$1.08 | 82.38M | 81.64M | Earnings Call Transcript |
| 2 Aug 2021 | Missed | -$1.33 | -$1.81 | 86.97M | 86.97M | Earnings Call Transcript |
| 4 May 2021 | Missed | -$1.24 | -$2.03 | 89.27M | 99.39M | Earnings Call Transcript |
| 11 Feb 2021 | Beat | -$1.15 | -$0.37 | 225.67M | 91.54M | Earnings Call Transcript |
| 27 Oct 2020 | Beat | -$1.26 | -$1.13 | 90.84M | 81.47M | |
| 30 Jul 2020 | Beat | -$1.54 | $0.41 | 231.78M | 61.70M | Earnings Call Transcript |
| 6 May 2020 | Missed | -$1.68 | -$1.91 | 29.75M | 36.30M | Earnings Call Transcript |
| 13 Feb 2020 | Beat | -$1.65 | -$1.62 | 36.25M | 35.59M | Earnings Call Transcript |
| 5 Nov 2019 | Missed | -$1.68 | -$1.96 | 22.11M | 25.8M | Earnings Call Transcript |
Ultragenyx Pharmaceutical Earnings report FAQs
When is Ultragenyx Pharmaceutical's next Earnings date?
The company has not set the next earnings date yet. The latest Ultragenyx Pharmaceutical's earnings date was on 4 May 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.